Keywords:
Pfizer (PFE) announces that JADE DARE (B7451050), a 26-week Phase 3 study, has met its co-primary and key secondary efficacy endpoints.
CAMEROON MAGAZINE - GM30/08/20211 Mins read66 ViewsKeywords:
Elgato, maker of the Stream Deck, just announced a teleprompter gadget. The...
ByCAMEROON MAGAZINE - GM18/10/2023Skip Bayless discussed his upbringing in Oklahoma and how it created a...
ByCAMEROON MAGAZINE - GM08/10/2023Francia Raisa supported her longtime friend Selena Gomez at her inaugural Rare...
ByCAMEROON MAGAZINE - GM06/10/2023Any huge fans of "Shrek" will have the opportunity to live like...
ByCAMEROON MAGAZINE - GM26/09/2023